The global spatial genomics and transcriptomics market was valued at $626.9 million in 2020 and is projected to reach $2,159.61 million by 2030, registering a CAGR of 13.6% from 2021 to 2030.
The studies of all genes and their associated mRNAs are correspondingly called genomics and transcriptomics. It is a method usually designed to assign cell types (mainly identified by mRNA readouts) to their locations in histological sections. This method can also be used to determine subcellular localization of mRNA molecules and their cellular heterogeneity in tissues, and tumors. In addition, spatial genomics and transcriptomics also provides information regarding immune cells as well as determine subcellular distribution of transcripts in various conditions.
Spatial genomics has tremendous potential in disease control as it helps to provide quantitative gene expression results, coupled with DNA & RNA visualization mapping within tissue parts. In spatial transcriptomics, sequencing techniques have a major share due to wide availability of sequencing platforms that help study RNA architecture in tissues or cells and use of advanced techniques within a laboratory setup to study biological organisms, which needs trained experts such as researchers and technicians. Genomics provides an overview of the complete set of genetic instructions provided by the DNA, while transcriptomics looks into gene expression patterns. The main driving factor that drives growth of the spatial genomics and transcriptomics market include, increase in adoption of spatial genomics and transcriptomics owing to its various application.
In addition, rise in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers, further supplement the global spatial genomics and transcriptomics market growth. Furthermore, growing preference toward personalized medicines also fuels growth of the market.
Conversely, unavailability of skilled professionals and ethical & legal limitations associated with the use of spatial genomics and transcriptomics technologies are expected to obstruct the growth of the market during forecast years. On the other hand, growth in innovations in spatial genomics and transcriptomics technologies are expected to offer profitable opportunities for the growth of the market during the forecast period.
The global spatial genomics and transcriptomics market is segmented on the basis of technique, product type, application, end user and region to provide a detailed assessment of the market. By technique, it is bifurcated into spatial transcriptomics, and spatial genomics analysis. The spatial transcriptomics is segmented into microdissection, fluorescent in-situ hybridization, in-situ sequencing, in-situ capturing, and in-silico construction.
In addition, the spatial genomics analysis is segmented into, fluorescence in-situ sequencing, and fluorescence microscopy. By product type, it is segmented into instruments, consumables, and software. By application, it is divided into, translational research, and drug discovery & development. Based on end user, it is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key market players profiled in the report include 10X Genomics, Inc., Akoya Biosciences, Inc., BioSpyder Technologies Inc., Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.), Dovetail Genomics, LLC, Fluidigm Corporation, Genomic Vision SA, Illumina, Inc., Lunaphore Technologies SA, Nanostring Technologies, Inc., Natera Inc., PerkinElmer Inc. (Horizon Discovery Group Plc), Rarecyte, Inc., Rebus Biosystems, LLC, Resolve Biosciences, S2 Genomic, Seven Bridges Genomics, Singular Genomics System, Inc., Tecan Group Ltd. (Nugen Technologies, Inc.), Ultivue, Inc., Veranome Biosystems LLC, and Vizgen Corporation.
The studies of all genes and their associated mRNAs are correspondingly called genomics and transcriptomics. It is a method usually designed to assign cell types (mainly identified by mRNA readouts) to their locations in histological sections. This method can also be used to determine subcellular localization of mRNA molecules and their cellular heterogeneity in tissues, and tumors. In addition, spatial genomics and transcriptomics also provides information regarding immune cells as well as determine subcellular distribution of transcripts in various conditions.
Spatial genomics has tremendous potential in disease control as it helps to provide quantitative gene expression results, coupled with DNA & RNA visualization mapping within tissue parts. In spatial transcriptomics, sequencing techniques have a major share due to wide availability of sequencing platforms that help study RNA architecture in tissues or cells and use of advanced techniques within a laboratory setup to study biological organisms, which needs trained experts such as researchers and technicians. Genomics provides an overview of the complete set of genetic instructions provided by the DNA, while transcriptomics looks into gene expression patterns. The main driving factor that drives growth of the spatial genomics and transcriptomics market include, increase in adoption of spatial genomics and transcriptomics owing to its various application.
In addition, rise in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers, further supplement the global spatial genomics and transcriptomics market growth. Furthermore, growing preference toward personalized medicines also fuels growth of the market.
Conversely, unavailability of skilled professionals and ethical & legal limitations associated with the use of spatial genomics and transcriptomics technologies are expected to obstruct the growth of the market during forecast years. On the other hand, growth in innovations in spatial genomics and transcriptomics technologies are expected to offer profitable opportunities for the growth of the market during the forecast period.
The global spatial genomics and transcriptomics market is segmented on the basis of technique, product type, application, end user and region to provide a detailed assessment of the market. By technique, it is bifurcated into spatial transcriptomics, and spatial genomics analysis. The spatial transcriptomics is segmented into microdissection, fluorescent in-situ hybridization, in-situ sequencing, in-situ capturing, and in-silico construction.
In addition, the spatial genomics analysis is segmented into, fluorescence in-situ sequencing, and fluorescence microscopy. By product type, it is segmented into instruments, consumables, and software. By application, it is divided into, translational research, and drug discovery & development. Based on end user, it is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key market players profiled in the report include 10X Genomics, Inc., Akoya Biosciences, Inc., BioSpyder Technologies Inc., Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.), Dovetail Genomics, LLC, Fluidigm Corporation, Genomic Vision SA, Illumina, Inc., Lunaphore Technologies SA, Nanostring Technologies, Inc., Natera Inc., PerkinElmer Inc. (Horizon Discovery Group Plc), Rarecyte, Inc., Rebus Biosystems, LLC, Resolve Biosciences, S2 Genomic, Seven Bridges Genomics, Singular Genomics System, Inc., Tecan Group Ltd. (Nugen Technologies, Inc.), Ultivue, Inc., Veranome Biosystems LLC, and Vizgen Corporation.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global spatial genomics and transcriptomics market along with the current trends and future estimations to elucidate the imminent investment pockets
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities
- Extensive analysis of the key segments of the industry helps to understand the application and products of spatial genomics and transcriptomics used across the globe
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market
KEY MARKET SEGMENTS
By Technique
- Spatial Transcriptomics
- Microdissection
- Fluorescent In-situ hybridization
- In-situ sequencing
- In-situ capturing
- In-silico construction
- Spatial Genomics Analysis
- Fluorescence In-situ sequencing
- Fluorescence Microscopy
By Product Type
- Instruments
- Consumables
- Software
By Application
- Translational Research
- Drug Discovery & Development
By End User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Research Institutes
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East and Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- 10X Genomics, Inc
- Akoya Biosciences, Inc
- BioSpyder Technologies Inc
- Bio-Techne Corporation (Advanced Cell Diagnostics, Inc)
- Dovetail Genomics, LLC
- Fluidigm Corporation
- Genomic Vision SA
- Illumina, Inc
- Lunaphore Technologies SA
- Nanostring Technologies, Inc
- Natera Inc
- PerkinElmer Inc (Horizon Discovery Group Plc)
- Rarecyte, Inc
- Rebus Biosystems, LLC
- Resolve Biosciences
- S2 Genomic
- Seven Bridges Genomics
- Singular Genomics System, Inc
- Tecan Group Ltd (Nugen Technologies, Inc)
- Ultivue, Inc
- Veranome Biosystems LLC
- Vizgen Corporation
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Landscape
Chapter 4: Spatial Genomics and Transcriptomics Market, by Technique
Chapter 5: Spatial Genomics and Transcriptomics Market, by Product Type
Chapter 6: Spatial Genomics and Transcriptomics Market, Application
Chapter 7: Spatial Genomics and Transcriptomics Market, by End-user
Chapter 8: Spatial Genomics and Transcriptomics Market, by Region
Chapter 9: Company Profiles
List of Tables
List of Figures
Executive Summary
According to a new report titled, “Spatial Genomics and Transcriptomic Market, by Technique, Product Type Application, End User: Global Opportunity Analysis and Industry Forecast, 2021–2030, the global spatial genomics and transcriptomic market size was valued at $0.62 billion in 2020 and is projected to reach $2.15 billion by 2030 registering a CAGR of 13.6% from 2021 to 2030.Spatial genomics & transcriptomic is a new discipline involving the identification of high-performance information concerning the organizational composition of tissue and cell content. It is a method that uses mRNA readouts to assign cell types to their positions in histological sections. This method may also be used to determine the subcellular localization and cellular heterogeneity of mRNA molecules in cancers and organs.
In addition, spatial genomics and transcriptomics provide information on immune cells and characterize the subcellular distribution of transcripts in a variety of situations. Spatial genomics has a lot of potential in disease control because it provides quantitative gene expression data as well as DNA and RNA visualization mapping into tissue components. In addition, sequencing techniques have a significant role in spatial transcriptomics, due to the widespread availability of sequencing platforms that aid in the study of RNA architecture in cells or tissues as well as the employment of advanced techniques inside a laboratory setup to investigate biological organisms.
The major factors that impact the growth of the spatial genomics and transcriptomic market include increase in adoption of spatial genomics and transcriptomics technologies, owing to their various applications. In addition, growth in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers also boost the growth of the market. Furthermore, rise in preference toward personalized medicines also fuels the growth of the market.
However, unavailability of skilled professionals and ethical & legal limitations associated with the use of spatial genomics and transcriptomic technologies hamper the growth of the market. On the other hand, growth in innovations in spatial genomics and transcriptomic technologies are expected to offer profitable opportunities for the growth of the market during the forecast period.
COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The global spatial genomics and transcriptomics market also declined in 2020 due to global economic recession led by COVID-19. However, market witness recovery in the year 2021, owing to increase in adoption of spatial genomics & transcriptomics to profile COVID-19 tissue autopsies as well as rise in biomarker identification and its use in drug discovery and development programs.
The global spatial genomics and transcriptomic market is segmented on the basis of technique, product type, application, end user, and region. By technique, it is bifurcated into spatial transcriptomics, and spatial genomics analysis. The spatial transcriptomics is further segmented into microdissection, fluorescent in-situ hybridization, in-situ sequencing, in-situ capturing, and in-silico construction. In addition, the spatial genomics analysis segment is segmented into, fluorescence in-situ sequencing, and fluorescence microscopy. The spatial genomics analysis segment was the major shareholder in 2020, owing to emerging potential of spatial genomic analysis as a cancer diagnostic tool, and advent of the fourth generation of sequencing.
By product type, it is segmented into instruments, consumables, and software. The consumables segment dominated the global spatial genomics and transcriptomic market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in adoption of consumables that are required to run the instruments across various stages of genome mapping from sample preparation to result derivation. Based on application, it is segmented into translational research, and drug discovery & development. The drug discovery & development acquired the largest share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in application of spatial genomic and transcriptomics technologies in drug discovery & development. By end user, it is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes.
The academic & research institutes segment acquired the largest share in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to surge in genomic research projects conducted by academic research institutes as well as collaboration among major players and universities for development of novel approaches to cure chronic conditions through genetic medicine.
Key Findings Of The Study
- Based on technique, the spatial genomic analysis held largest share in the global market in 2020
- Based on product type, the consumables held largest spatial genomics and transcriptomics market share in 2020 and is expected to remain dominant throughout the forecast period
- By application, the drug discovery & development dominates the global spatial genomics and transcriptomic market in 2020 and is anticipated to continue this trend during the forecast period
- By end user, the academic & research institutes held largest market share in 2020 and is anticipated to continue this trend during the forecast period
- Based on region, North America is expected to experience growth at the highest rate, registering a CAGR of 106% during the forecast period
- North America accounted for the largest share of the global spatial genomics and transcriptomic market in 2020, and is expected to remain dominant throughout the forecast period. This was attributed to presence of large number of key players as well as increase in number of large-scale genomics studies leveraging RNA sequencing in the region Furthermore, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders is expected to further boost the market growth
Companies Mentioned
- 10X Genomics, Inc.
- Akoya Biosciences, Inc.
- BioSpyder Technologies Inc.
- Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)
- Dovetail Genomics, LLC
- Fluidigm Corporation
- Genomic Vision SA
- Illumina, Inc.
- Lunaphore Technologies SA
- Nanostring Technologies, Inc.
- Natera Inc.
- PerkinElmer Inc. (Horizon Discovery Group Plc.)
- Rarecyte, Inc.
- Rebus Biosystems, LLC
- Resolve Biosciences
- S2 Genomic
- Seven Bridges Genomics
- Singular Genomics System, Inc.
- Tecan Group Ltd. (Nugen Technologies, Inc.)
- Ultivue, Inc.
- Veranome Biosystems LLC
- Vizgen Corporation.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 311 |
| Published | February 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 626.9 million |
| Forecasted Market Value ( USD | $ 2159.61 million |
| Compound Annual Growth Rate | 13.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
